Clinical Trial: Tumor-Derived FGF19
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition:
Colorectal Cancer
Breast Cancer
Healthy
Study Type: OBSERVATIONAL
Official Title: Translational Utility of Tumor-Derived FGF19 in a Novel Blood-Based Endocrine Suppression Approach
Brief Summary:
Identify and test thresholds, specificity and sensitivity for a potential cancer associated biomarker protein, FGF19, (and associated markers) for detection in human blood in the blood of breast and colorectal in cancer patients, and see if occurs at higher rates than healthy controls
Read more